| Phase 1 | 1 | |
| Phase 2/3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT03474029 | Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for… | Latent Tuberculosis | Recruiting | 2026-05-06 |
| NCT05766267 | Short-course Regimens for the Treatment of Pulmonary Tuberculosis | Tuberculosis, Pulmonary | Active, Not Recruiting | 2026-09-21 |
| Phase 1 | ||||
| NCT06962904 | CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults | Rotavirus Infections | Active, Not Recruiting | 2026-03-05 |
| Not specified | ||||
| NCT01772602 | The National Amyotrophic Lateral Sclerosis Registry | Amyotrophic Lateral Sclerosis | Recruiting | 2026-04-29 |
ALS (1)